510(k) · Cleared
ClearedStellaris Elite vision enhancement system
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bausch+Lomb · HQC Unit, Phacofragmentation
Cleared on Apr 19, 2017 as substantially equivalent to K133486 (Bausch & Lomb, 2014) and 1 other predicate after a 104-day review. Its family tree reaches back 7 generations to 1985. 1 later device descends from it.
- Decided
- Apr 19, 2017
- Review
- 104 days
- Class
- Class II
- Product code
- HQC
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 7 generations to K844373 (1985). 22 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 7 generations backK844373 O.M.S. Ultra-PhacoOptical Micro Systems, Inc. · 1985
- 6 generations backK981116 Sovereign Cataract Extraction SystemAllergan, Inc. · 1998 · Recalled
- 5 generations backK021566 InfinitiAlcon Laboratories, Inc. · 2002 · Recalled
- 4 generations backK063331 Bausch & Lomb NGX Microsurgical SystemBausch & Lomb, Inc. · 2006 · Recalled
- 3 generations backK082473 Bausch & Lomb Stellaris Microsurgical SystemBausch & Lomb, Inc. · 2009 · Recalled
- 2 generations backK101325 Stellaris PC Vision Enhancement SystemBausch & Lomb, Inc. · 2010 · Recalled
- 1 generation backK133242 Stellaris Vision Enhancement SystemBausch & Lomb · 2014
- This deviceK170052 Stellaris Elite vision enhancement systemBausch+Lomb · 2017
- Descendant · cites it directly · 0 of its ownK232084 Stellaris Elite vision enhancement systemBausch and Lomb · 2024
Most influential descendants
Showing 1 of 1 · See all- K232084Stellaris Elite vision enhancement systemBausch and Lomb · 2024 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −7 | K844373 | O.M.S. Ultra-Phaco | Optical Micro Systems, Inc. | 1985 | — |
| −6 | K981116 | Sovereign Cataract Extraction System | Allergan, Inc. | 1998 | 1 |
| −5 | K021566 | Infiniti | Alcon Laboratories, Inc. | 2002 | 3 |
| −4 | K063331 | Bausch & Lomb NGX Microsurgical System | Bausch & Lomb, Inc. | 2006 | 12 |
| −3 | K082473 | Bausch & Lomb Stellaris Microsurgical System | Bausch & Lomb, Inc. | 2009 | 4 |
| −2 | K101325 | Stellaris PC Vision Enhancement System | Bausch & Lomb, Inc. | 2010 | 1 |
| −1 | K133242 | Stellaris Vision Enhancement System | Bausch & Lomb | 2014 | — |
| 0 (this device) | K170052 | Stellaris Elite vision enhancement system | Bausch+Lomb | 2017 | — |
| +1 | K232084 | Stellaris Elite vision enhancement system | Bausch and Lomb | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2006 | 1 | 0 |
| 2008 | 1 | 0 |
| 2014 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in HQC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new HQC device
- #1 K261264 Stellaris Elite™ vision enhancement system…score 13.4 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K133486 | Stellaris PC Vision Enhancement SystemSummary page 4…rgery CFR References: 21 CFR 886.4670, 21 CFR 886.4150, 21 CFR 886.4390 Product Codes: HQC, HQE, HQF 3. Predicate Devices K133486 – Stellaris PC Vision Enhancement System, Bausch + Lomb K133242 – Stellaris Vision Enhancement System, Bausch + Lomb 4.… | 2014 |
| * | K133242 | Stellaris Vision Enhancement SystemSummary page 4…886.4150, 21 CFR 886.4390 Product Codes: HQC, HQE, HQF 3. Predicate Devices K133486 – Stellaris PC Vision Enhancement System, Bausch + Lomb K133242 – Stellaris Vision Enhancement System, Bausch + Lomb 4. Product Description The Bausch + Lomb Stellaris Elite Vision Enh… | 2014 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K232084 | Stellaris Elite vision enhancement system | 2024 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 32 years and passes through 6 companies; a new generation was cleared every 3.5 years on median.
- 11 of the 22 ancestors have a recall of any class.
- Of its descendants, K232084 (Bausch and Lomb, 2024) has gone furthest, with 0 descendants of its own.
- 2 other devices also cite its predicate K133486.
How does its category compare?
All HQC devicesHQC Unit, Phacofragmentation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · HQC
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · HQC
267in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · HQC
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · HQC
1,799in 2025
MAUDE reports naming product code HQC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 341 |
| 2008 | 4 | 162 | 1 | 444 |
| 2009 | 5 | 131 | 1 | 540 |
| 2010 | 3 | 142 | 22 | 2,431 |
| 2011 | 5 | 129 | 4 | 1,802 |
| 2012 | 5 | 125 | 1 | 2,277 |
| 2013 | 0 | — | 0 | 2,772 |
| 2014 | 4 | 135 | 1 | 2,740 |
| 2015 | 3 | 124 | 0 | 3,355 |
| 2016 | 1 | — | 0 | 3,374 |
| 2017 | 3 | 214 | 0 | 2,781 |
| 2018 | 0 | — | 2 | 2,416 |
| 2019 | 4 | 126 | 0 | 2,287 |
| 2020 | 4 | 227 | 0 | 1,217 |
| 2021 | 1 | — | 0 | 1,673 |
| 2022 | 4 | 245 | 5 | 1,907 |
| 2023 | 1 | — | 1 | 1,799 |
| 2024 | 5 | 197 | 0 | 2,120 |
| 2025 | 3 | 267 | 1 | 1,799 |
| 2026 | 3 | 115 | 0 | — |
What is it indicated for?
The Bausch + Lomb Stellaris Elite vision enhancement system is intended for the emulsification and removal of cataracts, anterior and posterior segment vitrectomy. The system is designed for use in both anterior and posterior segment surgeries. It provides capabilities for phacoemulsification, coaxial and bimanual irrigation/aspiration, bipolar coagulation, vitrectomy, viscous fluid injection/removal, and air/fluid exchange operations. The Stellaris Elite vision enhancement system configured with the laser module is additionally intended for retinal photocoagulation and laser trabeculRplasty.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K170052 · printed Nov 6, 2026
Cite this page
510(k) Report. “K170052: Stellaris Elite vision enhancement system.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170052
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026